Rethinking Remote Care
Providing safe care for patients outside the hospital is one of the greatest challenges of modern medicine. But how can patient monitoring be delivered in a way that meets clinical standards while remaining feasible for hospitals, care organisations and emergency teams? The company RedZinc addresses this challenge with connected real-time technology.
The hospital that fits in your pocket
An elderly patient is sitting in her living room, feeling slightly unsure as a mild pressure builds in her chest. For many people, this would be the moment to call an emergency team or head to an overcrowded A&E department. Yet in this case, all it takes is a quick look at her doctor’s app – and a short video call via a small wearable device that sits discreetly on her body.
Within seconds, the medical team has access to her vital signs, can assess in real time whether there is any risk, and can respond immediately. No unnecessary journeys, no long waiting times. Instead: safety within reach. This kind of care is not a vision of the future.
RedZinc and the BlueEye platform
The Irish–German company RedZinc has developed BlueEye, a platform that takes remote monitoring to a new level.
The solution combines a smartphone app, medical wearable accessories and a cloud-based monitoring dashboard where vital data, alerts and live video come together. The system was originally developed from clinical experience – particularly from situations in which swift decision-making and immediate access to information determine life-saving minutes. RedZinc therefore focuses not only on chronic patients or “Hospital at Home”, but also on emergency services, community care teams and mobile medical units.
It's distinctive hallmark is the combination of real-time video and continuous vital data collection. Clinicians see not only numbers – they see the situation itself. And that makes all the difference when decisions must be made.
From a strong idea to a scalable healthcare solution
In developing its healthcare solution, RedZinc faced a dual challenge.
On the one hand, the technological foundation was already strong; on the other, the company needed regulatory certainty, market validation, funding models and a coherent scaling strategy to enable growth in the highly regulated healthcare sector. Hospitals and emergency services require evidence, reliable data environments, robust data-protection concepts and a clear return-on-investment argument. The remote care market is expanding rapidly – but so is the competition. For RedZinc, it was clear that if BlueEye was to achieve international relevance, structured steps were essential, along with a partner capable of combining regulatory, technical and strategic expertise.
Scalability: from pilot project to integrated care platform
Scaling remote monitoring solutions is complex. It is not merely about delivering more devices. What matters is an ecosystem that enables interoperability, stable data centres, clearly defined processes and reliable clinical workflows. For RedZinc, this meant ensuring that:
- the technical platform was designed modularly so it could support a range of use cases – from home monitoring to emergency video transmission;
- the software remained open to partner solutions, ensuring that hospitals were not forced into proprietary systems;
- the transition from a single pilot project to an integrated standard workflow was underpinned by clear proof-of-value.
This step – from innovator to established provider – is essential in the healthcare market for achieving sustainable scale.
Technology like BlueEye requires stable financing, as clinical validation, certification, safety documentation and market entry are demanding processes. RedZinc therefore needed to structure its business model so that it would appeal to investors, articulate its investment case clearly and present its market traction in a systematic way. The goal was a combination of investment capital, clinical pilot projects and partnerships with healthcare organisations – a model that balances flexibility with predictable growth.
For RedZinc, collaborating with leap:up has been a decisive accelerator. The support begins exactly where young health-tech companies typically face their greatest barriers.
leap:up helps define and prioritise target customers, clinical partners and pilot environments, strengthening RedZinc’s strategic market entry. The team also receives support in building regulatory foundations, including structuring technical documentation and aligning with relevant health and data-protection requirements. In addition, leap:up assists with financial planning, preparing investor discussions and articulating a scalable business model. Workshops on customer journeys, partnership models and international positioning help refine BlueEye so that its existing strengths become clearly visible. In short: leap:up helps RedZinc turn a strong technology into a market-ready, growth-oriented solution.
With the BlueEye platform, RedZinc is now in a position to help shape remote care in everyday clinical practice. The company is ready to expand into new regions, new partnerships and new areas of application – from home-based care and community care to emergency services and mobile medical networks. RedZinc’s vision is clear: patients should be treated wherever they are – without compromising safety or quality. This goal continues to drive the company’s development and international expansion.